Repeated peribulbar injections of triamcinolone acetonide: A successful and safe treatment for moderate to severe Graves' ophthalmopathy

Acta Ophthalmologica

Volumn 87, Issue 1, 2009, Pages 58-64

  Bordaberry, Marcela ^a,b,c   Marques, Daniela L ^a,b   Pereira Lima, Julio C ^a,b   Marcon, Italo M ^a,b   Schmid, Helena ^a,b  

^a Santa Casa Complexo Hospitalar   (Brazil)

^b UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE   (Brazil)

^c NONE   (Brazil)

Author keywords

Clinical activity score; Graves' ophthalmopathy; Graves' optic neuropathy; Peribulbar triamcinolone

Indexed keywords

OPHTHALMOS; TRIAMCINOLONE ACETONIDE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; ENDOCRINE OPHTHALMOPATHY; FEMALE; HUMAN; INTRAOCULAR PRESSURE; MALE; OPTIC NERVE DISEASE; PRIORITY JOURNAL; REPEATED DRUG DOSE; THYROID DISEASE;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GLUCOCORTICOIDS; GRAVES OPHTHALMOPATHY; HUMANS; INJECTIONS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; OPTIC NERVE DISEASES; ORBIT; PILOT PROJECTS; PROSPECTIVE STUDIES; RETREATMENT; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; TRIAMCINOLONE ACETONIDE; VISUAL FIELDS;

EID: 58849164329     PISSN: 1755375X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1755-3768.2008.01171.x     Document Type: Article

References (40)

1. Allahabadia A, Heward JM, Nithiyananthan R, Gibson SM, Reuser TT, Dodson PM, Franklyn JA Gough SC (2001 MHC class II region, CTLA4 gene, and ophthalmopathy in patients with Graves' disease. Lancet 358 : 984 985.
2. Bartalena L (2005 Glucocorticoids for Graves' ophthalmopathy: how and when. J Clin Endocrinol Metab 90 : 5497 5499.
3. Bartalena L, Marcocci C, Chiovato L et al. (1983 Orbital cobalt irradiation combined with systemic corticosteroids for Graves' ophthalmopathy: comparison with systemic corticosteroids alone. J Clin Endocrinol Metab 56 : 1139 1144.
4. Bartalena L, Marcocci C, Gorman CA, Wiersinga WM Pinchera A (2003 Orbital radiotherapy for Graves' ophthalmopathy: useful or useless? Safe or dangerous? J Endocrinol Invest 26 : 5 16.
5. Baschieri L, Antonelli A, Nardi S, Alberti B, Lepri A, Canapicchi R Fallahi P (1997 Intravenous immunoglobulin versus corticosteroid in treatment of Graves' ophthalmopathy. Thyroid 7 : 579 585.
6. Ben Simon GJ, Syed H, Douglas R, Schwartz R, Goldberg RA McCann JD (2006 Clinical manifestations and treatment outcome of optic neuropathy in thyroid-related orbitopathy. Ophthalmic Surg Lasers Imaging 37 : 284 290.
7. Campbell JC (1989 Immunology of Graves' ophthalmopathy: retrobullbar histology and histochemistry. Acta Endocrinol 121 : 9 16.
8. Cant JS (1970 The assessment and treatment of endocrine exophthalmos. Proc R Soc Med 63 : 783 786.
9. Della Casa F (1970 Therapy of malignant exophthalmos. Ophthalmologica 161 : 145 151.
10. Donaldson SS, Bagshaw M Kriss J (1973 Supervoltage orbital radiotherapy for Graves' ophthalmopathy. J Clin Endocrinol Metab 37 : 276 285.
11. Ebner R, Devoto M, Weil D, Bordaberry M, Mir C et al. (2004 Treatment of thyroid associated ophthalmopathy with peribulbar injections of triamcinolone. Br J Ophthalmol 88 : 1380 1386.
12. Garber MI (1966 Methylprednisolone in the treatment of exophthalmos. Lancet 1 : 958 960.
13. Gebertt S (1961 Depot-methylprednisolone for subconjuntival and retrobulbar injections. Lancet 2 : 344 345.
14. Goldberg RA (2004 Orbital steroid injections - the ugly sister. Br J Ophthalmol 88 : 1359 1360.
15. Gorman CA, Garrity JA, Fatourechi V et al. (2001 A prospective, randomized, double-blind, placebo-controlled study of orbital radiotherapy for Graves' ophthalmopathy. Ophthalmology 108 : 1523 1534.
16. Hirooka K, Shiraga F, Tanaka S, Baba T Mandai H (2006 Risk factors for elevated intraocular pressure after trans-tenon retrobulbar injections of triamcinolone. Jpn J Ophthalmol 50 : 235 238.
17. Ivy HK (1972 Medical approach to ophthalmopathy of Graves' disease. Mayo Clin Proc 47 : 980 985.
18. Jonas JB (2006 Intravitreal triamcinolone acetonido: a change in paradigm. Ophthalmic Res 38 : 218 245.
19. Jonas JB, Degenring RF, Kreissig I, Akkoyun I Kamppeter BA (2005 Intraocular pressure elevation after intravitreal triamcinolone acetonide injecion. Ophthalmology 112 : 593 598.
20. Jonas JB, Spandau U, Kamppeter B, Vossmerbaeumer U, Hander B Sauder G (2006 Repeated intravitreal high-dosage injections of triamcinolone acetonide for diffuse diabetic macular oedema. Opthalmology 113 : 800 804.
21. Jones R Rhee DJ (2006 Corticosteroid-induced ocular hypertension and glaucoma: a brief review and update of the literature. Curr Opin Ophthalmol 17 : 163 167.
22. Kahaly G (1994 Immunohistochemical staining of retrobulbar adipose tissue in Graves' ophthalmopathy. Clin Immunol Immunopathol 73 : 53 62.
23. Kahaly G, Pitz S, Hommel G Dittmar M (2005 Randomized, single blind trial of intravenous versus oral steroid monotherapy in Graves' orbitopathy. J Clin Endocrinol Metab 90 : 5234 5240.
24. Kojima A, Ohno-Matsui K, Futagami S, Shimada N, Tokoro T Mochizuki M (2006 Trans-Tenon's retrobulbar triamcinolone infusion for myopic choroidal neovascularization. Acta Ophthalmol Scand 84 : 749 754.
25. Konstantopoulos A, Williams CP, Newsom RS Luff AJ (2006 Ocular morbidity associated with intravitreal triamcinolone acetonide. Eye 21 : 317 320.
26. Kusaka S, Ikuno Y, Ohguro N, Hori Y Tano Y (2007 Orbital infection following posterior subtenon triamcinolone injection. Acta Ophthalmol Scand 85 : 692.
27. Kvetny J, Puhakka KB Rohl L (2006 Magnetic resonance imaging determination of extraocular eye muscle volume in patients with thyroid-associated ophthalmopathy and proptosis. Acta Ophthalmol Scand 84 : 419 423.
28. Lennerstrand G, Tian S, Isberg B et al. (2007 Magnetic resonance imaging and ultrasound measurements of extraocular muscles in thyroid-associated ophthalmopathy at different stages of the disease. Acta Ophthalmol Scand 85 : 192 201.
29. Marcocci C, Bartalena L, Panicucci M et al. (1987 Orbital cobalt irradiation combined with retrobulbar or systemic corticosteroids for Graves' ophthalmopathy: a comparative study. Clin Endocrinol 27 : 33 42.
30. Marcocci C, Bartalena L, Bogazzi F, Bruno-Bossi G, Lepri A Pinchera A (1991 Orbital radiotherapy combined with high dose systemic glucocorticoids for Graves' ophthalmopathy is more effective than radiotherapy alone: results of a prospective randomized study. J Endocrinol Invest 14 : 853 860.
31. Mourits MP, Koorneef L, Wiersinga WM et al. (1989 Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: a novel approach. Brit J Ophthalmol 73 : 639 644.
32. Mourits MP, Prummel MF, Wiersinga WM Koornneef L (1997 Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy. Clin Endocrinol 47 : 9 14.
33. Oh J, Jung YS, Kim GS, Oh IK, Rho BK Huh K (2007 The effects of short-term exposure of triamcinolone acetonide on fibroblasts and retinal pigment epithelial cells. Acta Ophthalmol Scand 85 : 786 790.
34. 1H-magnetic resonance spectroscopy of retrobulbar tissue in Graves' ophthalmopathy. Am J Ophthalmol 128 : 715 719.
35. Paccola L, Jorge R, Barbosa JC, Costa RA Scott IU (2007 Anti-inflammatory efficacy of a single posterior subtenon injection of triamcinolone acetonide versus prednisolone acetate 1% eyedrops after pars plana vitrectomy. Acta Ophthalmol Scand 85 : 603 608.
36. Prummel MF, Mourits M, Blank L, Berghout A, Koornneef L Wiersinga WM (1993 Randomised double-blind trial of prednisona versus radiotherapy in Graves' ophthalmopathy. Lancet 342 : 949 954.
37. Thomas ID Hart JK (1974 Retrobulbar repository corticosteroid therapy in thyroid ophthalmopathy. Med J Aust 2 : 484 487.
38. Trobe JD, Glaser JS Laflamme P (1978 Dysthyroid optic neuropathy. Clinical profile and rationale of management. Arch Ophthalmol 96 : 1199 1209.
39. Tsujino K, Hirota S, Hagiwara M, Fukada S, Takada Y, Hishikawa Y, Kono M Abe M (2000 Clinical outcomes of orbital irradiation combined with or without systemic high-dose or pulsed corticosteroids for Graves' ophthalmopathy. Int J Radiat Oncol Biol Phys 48 : 857 864.
40. Wiersinga WM Prummel MF (2002 Graves' ophthalmopathy: a rational approach to treatment. Trends Endocrinol Metab 3 : 280 288.